- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
1982
0 new
Companies with a Value score of at least 3, ordered by Value score
1982 companies
AstraZeneca
Market Cap: US$216.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZNC.F
US$183.74
7D
0.6%
1Y
34.6%
Roche Holding
Market Cap: €263.3b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
RHO1
€6.90
7D
7.8%
1Y
n/a